Verum Partners’s Procter & Gamble PG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Buy
7,454
+307
+4% +$44.7K 0.16% 76
2026
Q1
$1.03M Buy
7,147
+1,217
+21% +$185K 0.2% 68
2025
Q4
$850K Sell
5,930
-1,145
-16% -$169K 0.17% 69
2025
Q3
$1.09M Sell
7,075
-171
-2% -$26.7K 0.23% 61
2025
Q2
$1.15M Buy
7,246
+406
+6% +$66.3K 0.27% 57
2025
Q1
$1.17M Buy
6,840
+394
+6% +$66K 0.31% 51
2024
Q4
$1.08M Buy
6,446
+122
+2% +$20.8K 0.31% 53
2024
Q3
$1.1M Buy
6,324
+88
+1% +$14.9K 0.32% 55
2024
Q2
$1.03M Buy
6,236
+144
+2% +$23.5K 0.33% 52
2024
Q1
$988K Buy
6,092
+22
+0.4% +$3.45K 0.35% 54
2023
Q4
$889K Buy
6,070
+379
+7% +$56.1K 0.35% 56
2023
Q3
$830K Buy
5,691
+757
+15% +$116K 0.37% 56
2023
Q2
$749K Sell
4,934
-9
-0.2% -$1.36K 0.68% 32
2023
Q1
$735K Buy
4,943
+11
+0.2% +$1.57K 0.79% 32
2022
Q4
$747K Buy
+4,932
New +$691K 0.92% 30

Other funds holding PG

Verum Partners's PG Position: Q2 2026 in Review

Verum Partners increased its Procter & Gamble (PG) stake by 4.3% in Q2 2026, buying an estimated $44.7K and bringing the position to 7,454 shares worth $1.09M. The position accounts for 0.16% of the portfolio, ranked #76.

Verum Partners first reported a position in PG in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.17M in Q1 2025. 4,006 funds tracked by Wall St. Rank hold PG as of Q2 2026.

  • Verum Partners held 7,454 shares of Procter & Gamble worth $1.09M as of Q2 2026.
  • Verum Partners bought 307 Procter & Gamble shares in Q2 2026, an estimated $44.7K.
  • Procter & Gamble made up 0.16% of Verum Partners's portfolio in Q2 2026, its #76 holding.
  • Verum Partners first reported a position in Procter & Gamble in Q4 2022 and has held it in 15 quarters since.
  • Verum Partners's Procter & Gamble position peaked at $1.17M in Q1 2025.
  • 4,006 funds tracked by Wall St. Rank held Procter & Gamble as of Q2 2026.

Based on Verum Partners's 13F filing for Q2 2026, filed 22 Jul 2026.